SmartExam enhances FibroScan® capabilities for improved management of fatty liver patients 

⬇️ Find out the 3 reasons why you should try SmartExam ⬇️
✅ Improve reliability in the diagnosis and monitoring of steatosis with Continuous CAP™.
With SmartExam, Echosens aims to improve monitoring of patient’s lifestyle change and therapeutic intervention.
✅ Extend usage among severely obese patients with deeper assessment of liver fibrosis and steatosis.
With SmartExam, the maximum recommended PCD is 45 mm, representing an increase of 28%.
✅ Dedicate more time to the patient care thanks to tasks automation.
With task automation features, operators can dedicate more time to patient care, and less time on performing FibroScan® examination.
📧 Interested by our SmartExam solution for your patients?
Contact us on echosens.com

Наука